WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”) announced today that it has entered into a definitive agreement with General Electric Company (“GE”) (NYSE: GE) to acquire the Biopharma business of GE Life Sciences (“GE Biopharma”) for a cash purchase price of approximately $21.4 billion. Given anticipated tax benefits from the transaction structure, the net […]
Partnership will leverage BenchSci’s AI to help scientists find the right reagents and enable ABclonal to compete on product quality BOSTON — ABclonal Technology, a new and growing provider of biology research reagents and services, and BenchSci, a life science machine learning company backed by Google’s AI fund, have entered into a partnership to provide […]
Partnership targets broader availability of new models and tools for cancer research CAMBRIDGE, Mass. — Cellaria, LLC, a scientific innovator that develops revolutionary new models for cancer and other diseases, today announced a new distribution partnership with Rockland Immunochemicals, Inc. (Rockland), a life science supplier and manufacturer that specializes in antibodies and antibody-based tools for research applications […]
VICTORIA – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) has received a five-year Indefinite Delivery/Indefinite Quantity (ID/IQ) subcontract from Leidos Biomedical Research, Inc., which currently operates the Frederick National Laboratory for Cancer Research for the National Cancer Institute (NCI). Under the subcontract, IPA will discover and produce rabbit monoclonal antibodies […]
For a few years now, molecular biology has been completely dominated by single cell technologies. It all started with single cell RNA-Seq, but rapidly branched out to other applications, such as epigenomics, regulation (ATAC-Seq and ChIP-Seq), and proteomics (for a high-level overview, we suggest an excellent recent articlein Nature Reviews Genetics). Analysis of single cell data sets […]
New REAlease® Fluorochrome Technology available BERGISCH GLADBACH, February 21, 2019 – The new REAlease® Releasable Antibodies from Miltenyi Biotec are based on the ground-breaking REAlease® Fluorochrome Technology and allow for the removal of antibodies after cell sorting in just one step. Sorted cells are label-free to provide maximal flexibility in downstream applications. Multicolor flow cytometry-based cell sorting is the method of […]
Burlington, MA 08 February 2019 – RedShift BioAnalytics (RedShiftBio) appoints new West Coast Sales and Support Manager to help satisfy demand for its award-winning protein characterization system. Subodh Nimkar joins the team to support sales on the West Coast of the United States. The AQS3pro was introduced and completed a very success beta program with […]
Scientific Laboratory Supplies SLS are pleased to announce that they have signed an agreement with Pop-Bio Imaging, based in Cambridge, to be the exclusive UK distributor for the exciting new Vü imaging system for gels and blots. Vü is no ordinary gel documentation system however. The Pop-Bio Imaging system uses no cameras, no lenses, filters, […]
Bio-Works had 236 active customers at the end of 2018. This means that 131 new customers have been added during the year, which corresponds to an increase of 125 %. Of these customers, six are now working in production scale and another 49 customers are working with scale-up, four of which are working in late […]
HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of a range of recombinant monoclonal anti-idiotypic antibodies that inhibit the binding of eculizumab (Soliris) to its target, complement C5 protein. These anti-eculizumab antibodies detect free drug and are designed for use in […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
